Patents

Vactech is the sole owner of the patents and patent applications covering the preventive Type 1 Diabetes vaccine. In addition, Vactech’s patents cover antiviral drugs and diagnostic assays for Type 1 Diabetes enabling the company to build a product family around diabetes prevention and cure. The IPR portfolio includes in addition international patents covering virus-based products to treat and prevent Allergies, Asthma and Celiac Disease.


Please, find attached and download Vactech patents and patent applications and a description how this IPR is related to our projects and products.

ProjectDescriptionIPR

Type 1 Diabetes, T1D

Preventive enterovirus vaccine

Indication: Prevention of T1D and enterovirus infections

Background patent granted in USA, EPO

Download WO version …

Multivalent CBV vaccine patent pending in USA, EPO

Download WO version …

 

Other preventive and therapeutic antiviral agents (drugs, antibodies)

Indication: Treatment of individuals who have subclinical or clinical T1D, prevention of T1D

 

Diagnostic tests for diabetogenic enteroviruses

Indication: Identification of individuals infected by a diabetogenic virus and treatable by antiviral agents, monitoring the efficacy of antiviral treatments

Patent granted in EPO

Download WO version …


ProjectDescriptionIPR

Celiac Disease, CD

Preventive enterovirus vaccine

Indication: Prevention of CD and enterovirus infections

Patent granted in EPO

Download WO version …

 

Other preventive and therapeutic antiviral agents (drugs, antibodies)

Indication: Treatment of individuals who have subclinical clinical CD, prevention of T1D

 

Diagnostic tests for identification of individuals infected by an enterovirus

Indication: Identification of individuals infected by a CD associated virus and treatable by antiviral agents, monitoring the efficacy of antiviral treatments


ProjectDescriptionIPR

Allergic Diseases and Asthma

Entero/rhinovirus vaccines and antivirals

Indication: Prevention of allergic diseases and asthma

Patent granted in USA, EPO, Russia, Australia, New Zeeland, South Africa

Patent pending in South Korea

Download WO version …

 

Entero/rhinovirus based immunomodulators

Indication: Prevention and treatment of allergic diseases and asthma


ProjectDescriptionIPR

Technologies

Inactivated enterovirus vaccines

Virus Like Particles, VLP (IMAVAC ™)

Included in patents and patent applications